KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Work In Process (2016 - 2018)

Teva Pharmaceutical Industries filings provide 10 years of Work In Process readings, the most recent being $148.0 million for Q4 2018.

  • On a quarterly basis, Work In Process fell 75.21% to $148.0 million in Q4 2018 year-over-year; TTM through Dec 2018 was $148.0 million, a 75.21% decrease, with the full-year FY2018 number at $148.0 million, down 75.21% from a year prior.
  • Work In Process hit $148.0 million in Q4 2018 for Teva Pharmaceutical Industries, down from $609.0 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $646.0 million in Q1 2018 to a low of $148.0 million in Q4 2018.
  • Median Work In Process over the past 5 years was $601.0 million (2017), compared with a mean of $495.9 million.
  • Biggest five-year swings in Work In Process: skyrocketed 189.25% in 2016 and later crashed 75.21% in 2018.
  • Teva Pharmaceutical Industries' Work In Process stood at $638.0 million in 2014, then tumbled by 70.85% to $186.0 million in 2015, then skyrocketed by 189.25% to $538.0 million in 2016, then increased by 10.97% to $597.0 million in 2017, then crashed by 75.21% to $148.0 million in 2018.
  • The last three reported values for Work In Process were $148.0 million (Q4 2018), $609.0 million (Q3 2018), and $605.0 million (Q2 2018) per Business Quant data.